Today is an exciting day for the Dorsata team and for the 1500+ clinicians that use our software every day. We are pleased to announce that we recently closed a $1.1m seed round, led by the incredible team at QED Investors with participation from other institutional, strategic, and individual investors such as 5 Cap Ventures, 1776, the Partnership Fund for NYC, and the co-founders of Sheridan Healthcare, a $2.5bn physician services company. These investors have all grasped the great potential that we have to improve quality, lower costs and drive clinician engagement through the expansion of our platform and the increased use of care pathways.
Peter Hotz of 5 Cap Ventures and the former head of Walgreens' retail clinics business has joined our board. I couldn't be happier with the team of investors, mentors, software developers, and clinicians that we have assembled.
In addition to supporting our large rollouts at Barnes-Jewish in St. Louis and Penn Medicine in Philadelphia, 2016 is about doing two things well:
- Continuing to grow our community of clinicians that use our technology every day to build, collaborate, and share best practices.
- Demonstrate Dorsata's ability to drastically reduce the amount of time clinicians spend doing mundane tasks like documentation and data entry – thereby freeing them up to focus on patients.
To accomplish these goals, we’re selectively recruiting a few key individuals to join our team. We are specifically hiring for full-stack software engineering and business development roles, but we want to meet those that are interested and motivated by our mission.
Over the coming weeks, we will be announcing a number of other significant initiatives, so check back here often!